naltrexone with glp 1 GLP-1 + Combination: Biomarker Insights Wegovy and Naltrexone Together: Safety

Matrix/collagen support and fibroblast migration in tendon/ligament models

Saunders has prescribed Wegovy to many people over the age of 60, who take several other medications for weight-related health complications

Our special reports key findings include the following: Labeled indications for GLP-1 RAs (i.e., patients with body mass index [BMI] 30 kg/m2 or 27 kg/m2 with obesity-related comorbidities) follow a longstanding consensus established by the National Heart, Lung, and Blood Institutes 1998 guidelines on obesity management

Steinkamp, University of New Mexico, United States Shun Li, University of Pittsburgh, United States Brian Brown, Icahn School of Medicine at Mount Sinai, United States Updates Copyright 2025 Xu, Chen, Tan and Tan

Identification of new indications for FDA-approved medications can occur in a serendipitous fashion in which a drug shows unexpected benefits in clinical trials for its original indication